Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
Net Income Contraction
Below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-167.38M
↓ 225% below average
Average (6y)
$-51.56M
Historical baseline
Range
High:$111.21M
Low:$-167.38M
CAGR
+50.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-167.38M | -9.3% |
| 2023 | $-153.16M | -237.7% |
| 2022 | $111.21M | +269.6% |
| 2021 | $-65.57M | -26.6% |
| 2020 | $-51.80M | -158.5% |
| 2019 | $-20.04M | -41.2% |
| 2018 | $-14.19M | - |